Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Prepaid Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Prepaid Assets over the past 15 years, most recently at $1.5 million for Q2 2025.

  • Quarterly results put Prepaid Assets at $1.5 million for Q2 2025, up 1.04% from a year ago — trailing twelve months through May 2025 was $1.5 million (up 1.04% YoY), and the annual figure for FY2025 was $1.5 million, up 1.04%.
  • Prepaid Assets for Q2 2025 was $1.5 million at Lifecore Biomedical, Inc. \De\, down from $2.5 million in the prior quarter.
  • Over the last five years, Prepaid Assets for LFCR hit a ceiling of $5.9 million in Q1 2021 and a floor of $1.3 million in Q3 2021.
  • Median Prepaid Assets over the past 5 years was $1.9 million (2023), compared with a mean of $2.4 million.
  • Biggest five-year swings in Prepaid Assets: plummeted 90.5% in 2021 and later soared 195.32% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Prepaid Assets stood at $1.4 million in 2021, then rose by 16.1% to $1.7 million in 2022, then rose by 10.28% to $1.8 million in 2023, then surged by 56.42% to $2.9 million in 2024, then plummeted by 49.62% to $1.5 million in 2025.
  • The last three reported values for Prepaid Assets were $1.5 million (Q2 2025), $2.5 million (Q1 2025), and $2.9 million (Q4 2024) per Business Quant data.